Reference health

Tumor-infiltrating B cells producing antitumor active immunoglobulins in resected HCC prolong patient survival

https://doi.org/10.18632/oncotarget.20238
CiteStamped reference-health badge
25/25 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 25 checked references that resolve
resolves10.3322/caac.20107
Global cancer statistics
resolves10.1016/j.annepidem.2013.11.006
Local geographic variation in chronic liver disease and hepatocellular carcinoma: contributions of socioeconomic deprivation, alcohol retail outlets, and lifestyle
resolves10.1371/journal.pone.0068193
Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization
resolves10.1111/jgh.12418
Intrahepatic interleukin‐17<sup>+</sup><scp>T</scp> cells and <scp>F</scp>ox<scp>P</scp>3<sup>+</sup> regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma
resolves10.1002/hep.27728
Tumor‐infiltrating, interleukin‐33–producing effector‐memory CD8+ T cells in resected hepatocellular carcinoma prolong patient survival
resolves10.1016/j.jhep.2006.09.004
Immunotherapy of hepatocellular carcinoma
resolves10.1586/egh.10.18
Immunotherapy of hepatocellular carcinoma
resolves10.1158/1078-0432.CCR-12-3497
Margin-Infiltrating CD20+ B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma
resolves10.1136/gutjnl-2015-310814
Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma
resolves10.1158/1078-0432.CCR-12-0234
CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer
resolves10.1002/hep.28020
Chemokine (C‐X‐C motif) receptor 3–positive B cells link interleukin‐17 inflammation to protumorigenic macrophage polarization in human hepatocellular carcinoma
resolves10.1016/j.canlet.2014.09.026
Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway
resolves10.1016/j.intimp.2014.07.007
Dynamic analysis of tumor-associated immune cells in DEN-induced rat hepatocellular carcinoma
resolves10.1371/journal.pone.0110064
CXCL17 Expression Predicts Poor Prognosis and Correlates with Adverse Immune Infiltration in Hepatocellular Carcinoma
resolves10.3748/wjg.v19.i1.8
Tumor-infiltrating B cells come into vogue
resolves10.1093/bioinformatics/btu586
Translating bioinformatics in oncology: guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesis
resolves10.1016/S1525-1578(10)60455-2
Analysis of Microarray Data Using Z Score Transformation
resolves10.1158/0008-5472.CAN-10-2607
A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients
resolves10.1371/journal.pone.0076115
Expression of the B-Cell Receptor Component CD79a on Immature Myeloid Cells Contributes to Their Tumor Promoting Effects
resolves10.4049/jimmunol.154.1.97
CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.
resolves10.1016/j.jprot.2014.12.020
Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC–MS–MRM in liver disease
resolves10.1080/2162402X.2015.1057387
Mucin 1-specific B cell immune responses and their impact on overall survival in breast cancer patients
resolves10.1002/eji.201444625
Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL‐10
resolves10.4049/jimmunol.0803773
In Vivo Sensitized and In Vitro Activated B Cells Mediate Tumor Regression in Cancer Adoptive Immunotherapy
resolves10.18632/oncotarget.7869
IL-17A promotes migration and tumor killing capability of B cells in esophageal squamous cell carcinoma
The 2 references without a DOI — listed, not checked
no DOI — not checkedNew possibilities in hepatocellular carcinoma treatment
no DOI — not checkedCorrelation analysis of peripheral blood T cell subgroups, immunoglobulin and prognosis of early hepatocellular carcinoma after hepatectomy
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.18632/oncotarget.20238"><img src="https://citestamp.com/citestamped/10.18632/oncotarget.20238/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.18632/oncotarget.20238/badge.svg)](https://citestamp.com/citestamped/10.18632/oncotarget.20238)